Ignite Creation Date:
2025-12-24 @ 5:40 PM
Ignite Modification Date:
2026-02-21 @ 1:36 AM
Study NCT ID:
NCT01999868
Status:
COMPLETED
Last Update Posted:
2019-01-15
First Post:
2013-11-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-03-19
Start Date Type:
ACTUAL
Primary Completion Date:
2017-12-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-03-01
Completion Date Type:
ACTUAL
First Submit Date:
2013-11-26
First Submit QC Date:
None
Study First Post Date:
2013-12-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-12-04
Results First Submit QC Date:
None
Results First Post Date:
2018-12-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-12-26
Last Update Post Date:
2019-01-15
Last Update Post Date Type:
ACTUAL